(Total Views: 283)
Posted On: 04/19/2020 1:35:18 PM
Post# of 36542
Seems NGIO has protected itself against your fears, GMIN. You may be right on the royalties. NGIO needs $ - I'm hoping China paid for the expenses and the $5 Mil. We'll know soon:
"NGIO has signed a development and commercial licensing agreement with partners in China to develop a vaccine against the SARS-COV-2 coronavirus. The agreement provides exclusive rights to the Ii-Key- SARS-COV-2 peptide vaccines in China; NGIO retains worldwide rights to the Ii-Key peptide vaccines."
"NGIO has signed a development and commercial licensing agreement with partners in China to develop a vaccine against the SARS-COV-2 coronavirus. The agreement provides exclusive rights to the Ii-Key- SARS-COV-2 peptide vaccines in China; NGIO retains worldwide rights to the Ii-Key peptide vaccines."
(0)
(0)Scroll down for more posts ▼
